The Outrageous Cost of Staying Alive: Revlimid and US Drug Pricing

The High Cost of Revlimid

• 💊 David Armstrong, diagnosed with multiple myeloma, relies on the drug Revlimid to stay alive, with each pill costing nearly $1,000.
• 💰 The drug, which costs only 25 cents to manufacture, is a significant financial burden, with a year's supply costing tens of thousands of dollars.
• 📈 Revlimid's price has been increased 26 times since its introduction, highlighting a unique US drug pricing system.

The Troubled History of Thalidomide and Revlimid

• ⚠️ Revlimid is an analog of thalidomide, a drug with a dark history of causing severe birth defects in the 1950s and 60s.
• 🔬 The drug was initially banned in the US but found use for leprosy and later, through patient and doctor-led research, as a treatment for multiple myeloma.
• 🧬 Cellgene, the company behind Revlimid, developed analogs to secure stronger patents and increase potency, leading to the drug's eventual market approval.

Market Exclusivity and Price Gouging

• 📉 Cellgene set an initial price of $55,000 per year for Revlimid, a price that has escalated dramatically over time.
• 🚫 The company actively prevented generic competition for decades by refusing to sell samples needed for bioequivalence testing, despite regulatory scrutiny.
• 🤝 Deals with generic manufacturers and limited market entry in 2022 have kept prices for both brand-name and generic Revlimid exceptionally high.

US Drug Pricing vs. Global Markets

• 🌍 Unlike other developed nations with single-payer systems and price negotiation, the US has a fragmented payer system that lacks strong negotiating power.
• 📊 Other countries analyze drug cost-effectiveness and negotiate prices, resulting in significantly lower costs compared to the US.
• 🏛️ While executive orders aim to lower drug prices, they often lack concrete mechanisms, and legislative or regulatory changes are complex and prone to legal challenges.

Patient Impact and Future Outlook

• 💔 Patients with high co-pays or deductibles often struggle to afford Revlimid, sometimes resorting to borrowing against homes or importing the drug.
• 💰 Even the generic version of Revlimid remains expensive, costing around $17,500 per month, due to agreements between brand and generic manufacturers.
• 🌱 There is a call to support research for new treatments while acknowledging the financial strain of current life-saving medications on patients and the healthcare system.